Quel est le prix pour Sunshine Biopharma, Inc. (SBFM)

Le prix pour Sunshine Biopharma, Inc. (SBFM) est $1.16

Quelle est la capitalisation boursière pour Sunshine Biopharma, Inc. (SBFM)

La capitalisation boursière pour Sunshine Biopharma, Inc. (SBFM) est $580.69K

Sunshine Biopharma, Inc. (SBFM) Prix et Capitalisation Boursière

Sunshine Biopharma, Inc. operates as a pharmaceutical entity and a provider of nutritional supplements, primarily dedicating its efforts to the research and development of novel anticancer therapies. A key pipeline candidate is Adva-27a, a GEM-difluorinated C-glycoside derivative of podophyllotoxin, designed to combat a broad spectrum of malignancies, including leukemia, lymphoma, testicular, lung, brain, prostate, bladder, colon, ovarian, and liver cancers. Notably, Adva-27a also demonstrates efficacy against multidrug-resistant cancer cells, encompassing pancreatic, breast, small-cell lung, and uterine sarcoma cells. The company is also progressing SBFM-PL4, a compound under development as an anti-coronavirus treatment. In addition to its drug development, Sunshine Biopharma markets a range of nutritional products, such as the Essential 9 tablet and the Essential Calcium-Vitamin D supplement, alongside other scientifically formulated dietary aids. A collaboration with the University of Georgia supports the ongoing advancement of SBFM-PL4 as an anti-coronavirus agent. The firm's headquarters are situated in Pointe-Claire, Canada.

Prix pour SBFM	L’actif B	La capitalisation boursière de B	Résultats
$10,926,161 $580.69K	NVDA	$5.470T	+941,910,316.72%
$8,923,595 $580.69K	AAPL	$4.467T	+769,275,306.69%
$8,338,916 $580.69K	GOOG	$4.174T	+718,871,980.51%
$7,391,418 $580.69K	MSFT	$3.700T	+637,191,103.70%
$5,701,946 $580.69K	AMZN	$2.854T	+491,546,943.03%

Prix pour SBFM

L’actif B

La capitalisation boursière de B

Résultats

$10,926,161 $580.69K